Your browser is out-of-date!

Update your browser to view this website correctly.

Disclaimer
To continue, please select your country of domicile and investor type. Depending on your domicile and the investor type that you select, you will have full or restricted access to the information due to legal reasons.

Retail clients: according to Art. 4 Abs. 2 FinSA

Professional/Institutional investors: according to Art. 4 paragraph 3-5 and Art. 5 paragraph 1 and 3-4 FinSA and Art. 10 paragraph 3 and 3ter CISA in conjunction with Art. 6a CISO

Important

Principles 

By using the website www.bellevue.ch, you confirm that you have read, understood and accepted the general information provided by the Bellevue Group AG as well as these legal provisions. These may be subject to change and the use of the site may be restricted or terminated at any time without prior notice.

No recommendation and/or offer for subscription (or for purchase) and/or redemption (or for sale)

The information, products, data, services, tools and documents contained or described on this site ("website content") are for information purposes only and constitute neither an advertisement or recommendation nor an offer or solicitation (to buy) or redemption (sell) investment instruments, to effect any transaction or to enter into any legal relations.

The financial products mentioned on this site are not suitable for all investors. The information contained on this site does not constitute a financial, legal, fiscal or any other recommendation. Investment or other decisions should not be made solely on the basis of this document. In particular, you should not enter into any investment before you have read the corresponding fund agreement or legal prospectus, the annual and semi-annual reports, the articles of association (as far as they are applicable), as well as all other documents, as required in accordance with local legislation or the regulations applied in the legal jurisdictions or countries in which the corresponding investment fund has been licensed or approved for public offer or sale to the public.rlich sind.

The financial products mentioned on this site are not suitable for all investors. The information contained on this site does not constitute a financial, legal, fiscal or any other recommendation. Investment or other decisions should not be made solely on the basis of this document. In particular, you should not enter into any investment before you have read the corresponding fund agreement or legal prospectus, the annual and semi-annual reports, the articles of association (as far as they are applicable), as well as all other documents, as required in accordance with local legislation or the regulations applied in the legal jurisdictions or countries in which the corresponding investment fund has been licensed or approved for public offer or sale to the public.

In order to determine whether the investment in shares of a certain investment fund meets your specific requirements and matches your envisaged risks, we recommend that you contact an independent financial adviser. Furthermore, we recommend that you consult an independent tax adviser in order to obtain information on the tax regulations relating to a specific investment in your legal jurisdiction and with regard to your personal circumstances. In particular tax treatment depends on individual circumstances and may be subject to change.

As the funds are recognised (ie. registered) but not authorised in the UK, the UK Financial Services Authority's financial services compensation scheme does not apply to investments in the fund but the Financial Services Authority regulated firm approving this document for the purposes of UK regulation has taken reasonable steps to satisfy itself that Bellevue will deal in an honest and reliable way and is so satisfied.

Performance

Past performance is not an indication or guarantee of the future performance of the investment. The value of investments may be subject to fluctuations and, under certain circumstances, investors may not get back the full amount invested. The performance data are calculated without taking account of commissions and costs that result from subscriptions and redemptions and commissions and costs have a negative impact on performance. Changes in foreign-exchange rates may also cause the value of investments to go up or down.

Target group of the sites 

The sites are intended exclusively for use by legal entities and natural persons having their registered office or residing in countries in which the investment funds or the related subfunds or share classes of the Bellevue Group have been properly licensed or approved for public offer or sale in accordance with the applicable local legislation. The funds are currently registered for public distribution offer in the following countries: Luxembourg, Switzerland, Germany, Austria, Spain and Portugal. In all other countries, the funds may, if any, via "Private Placement" according to the local applicable laws.

It is explicitly stated, that alternative fund products are not allowed for public distribution in any country and that they may only and exclusively be solicited to institutional and qualified private investors according to the applicable local laws of each country.

The information and services provided on the sites are not intended for offer to or use by legal entities or natural persons in legal jurisdictions or countries in which the offer or use thereof would violate local legislation or legal provisions, or in which business units forming part of Bellevue Group would be subject to registration requirements in such jurisdictions or countries. Legal entities or natural persons to which such prohibitions apply must not access or use these sites.

The Bellevue funds have NOT been licensed for public offer or sale to the public in the United States in accordance with the US Investment Company Act of 1940 or the US Securities Act of 1933, or in Canada, Japan, Taiwan, Malaysia, Hong Kong or Israel in accordance with the laws in force in those countries. Therefore, particular importance is attached to ensuring that these sites are not intended for legal entities or natural persons, who have their registered office or who reside in such countries, their territories or dependencies or who, on account of their citizenship or similar status, are subject to the law of one of these countries.

Fund documents Luxembourg Fund

Bellevue SICAV: The Bellevue Funds (Lux) SICAV is admitted for public offering and distribution in Switzerland . Representative agent in Switzerland   Waystone Fund Services (Switzerland) SA, Avenue Villamont 17, CH-1005 Lausanne and paying agent in Switzerland: DZ PRIVATBANK (Schweiz) AG Münsterhof 12, PO Box, CH-8022 Zürich. Austria: Paying and information agent: Zeidler Legal Process Outsourcing Limited., 19-22 Lower Baggot Street, Dublin 2, D02 X658, Ireland. Germany: information agent: Zeidler Legal Process Outsourcing Limited., 19-22 Lower Baggot Street, Dublin 2, D02 X658, Ireland. Spain: The Bellevue Funds (Lux) SICAV is registered with the CNMV under the number 938. Paying and information agent: atl Capital, Calle de Montalbán 9, ES-28014 Madrid.  Prospectus, Key Investor Information Document (“KID”), the articles of association as well as the annual and semi - annual reports of the Bellevue Funds under Luxembourg law are available free of charge from the above mentioned representative, paying, facilities and information agents as well as from Bellevue Asset Management AG, Theaterstrasse 12, CH-8001 Zurich.

Bellevue Asset Management (Deutschland) GmbH: You can obtain the sales prospectus, the annual reports and the german key investor information documents free of charge from Bellevue Asset Management (Deutschland) GmbH, and also from banks and financial advisers. Paying agent in Switzerland is DZ PRIVATBANK (Schweiz) AG, Münsterhof 12, PO Box, CH-8022 Zurich. The swiss agent is IPConcept (Schweiz) AG, In Gassen 6, PO Box, CH-8022 Zurich. In Switzerland you can obtain sales prospectus, the annual reports and the german key investor information documents free of charge from the agent and also from the paying agent. 

Fund documents Bellevue Entrepreneur Switzerland

Prospectus, Key Investor Information Document („KID“), fund contract as well as the annual and semi - annual reports of the Bellevue Fund under Swiss law are available free of charge from: Switzerland : PMG Fonds Management AG, Dammstrasse 23, 6300 Zug or Bellevue Asset Management AG, Theaterstrasse 12, CH-8001 Zurich.

Fund documents Bellevue Funds and Bellevue Healthcare Strategy

Prospectus, Key Investor Information Document („KID“), fund contract as well as the annual and semi - annual reports of the Bellevue Medtech and Services fund established under Swiss law in the category "Other Funds for Traditional Investments" are available free of charge from : Switzerland : Swisscanto Fondsleitung AG, Bahnhofstrasse 9 , CH - 8001 Zürich or Bellevue Asset Management AG, Theaterstrasse 12, CH-8001 Zurich.

Fund documents StarCapital Multi Income and StarCapital Dynamic Bonds

Prospectus, the key information document ("PRIIP-KID"), the management regulations and the semi-annual and annual report are available free of charge in German from Bellevue Asset Management (Deutschland) GmbH, your advisor or intermediary, the paying agents, the relevant custodian bank or from the management company IPConcept (Luxembourg) S.A. (société anonyme), 4, rue Thomas Edison, L-1445 Luxembourg, Luxembourg, https://www.ipconcept.com. For information on opportunities and risks as well as tax information, please refer to the current detailed sales prospectus. Further information on investor rights can be found on the Management Company's website (https://www.ipconcept.com). The management company may decide to cancel the arrangements it has made for the distribution of the units of its collective investment undertakings in accordance with Article 93a of Directive 2009/65/EC and Article 32a of Directive 2011/61/EU.

Fund documents Bellevue Option Premium fund

Prospectus, the key information document ("PRIIP-KID"), and the semi-annual and annual reports are available free of charge in German from Bellevue Asset Management (Deutschland) GmbH, your advisor or intermediary, the paying agents, the responsible depositary (UBS Europe SE, Bockenheimer Landstrasse 2-4, D-60306 Frankfurt am Main) or from the management company Universal-Investment-Gesellschaft mbH, Theodor-Heuss-Allee 70, D-60486 Frankfurt am Main, https://www.universal-investment.com. For information on opportunities and risks as well as tax information, please refer to the current detailed sales prospectus. Further information on investor rights can be found on the Management Company's website (https://www.universal-investment.com). The management company may decide to cancel the arrangements it has made for the distribution of the units of its collective investment undertakings in accordance with Article 93a of Directive 2009/65/EC and Article 32a of Directive 2011/61/EU.

Data protection

By accessing this website you state that you agree with the data protection statement. If you do not agree with this statement you should refrain from accessing any further pages of this website. This statement may be updated at any time. We therefore recommend that you check this statement regularly.

Confirmation

By clicking on "Accept", you confirm that you agree to the legal provisions. 

Low fee. 



High impact.

 

Product page

Top healthcare stocks in an active ETF 

The healthcare market is one of the most attractive structural growth markets in the world. The Bellevue Healthcare ETF – an exchange-traded, transparent and cost-effective investment vehicle – offers you easy access to an actively managed portfolio of healthcare sector leaders. You also benefit from Bellevue Asset Management’s long-standing expertise as a healthcare investor.

Why invest in the healthcare sector? 

Healthcare in investment portfolios – growth potential with a diversification effect 

Driven by demographic aging, the growing prevalence of lifestyle-related diseases, and strong innovation, the healthcare sector has become one of the largest growth markets in the world – and its potential is immense. The sector also offers relevant diversification benefits for client portfolios thanks to its comparatively low correlation with the broader stock market.

Why Active ETF?

More than an index – targeted stock selection makes a difference when investing in the healthcare universe 

An active ETF (exchange traded fund) combines the advantages of an ETF with the potential rewards of active management. The Bellevue Healthcare ETF is managed by a highly experienced portfolio management team. While a passive ETF replicates a chosen index, an active ETF is designed to outperform the index. The composition of the ETF portfolio and the individual weightings are actively monitored and adjusted to address evolving circumstances and opportunities with the aim of generating an excess return.  

The specific characteristics of the healthcare sector are tailored to an active management approach and the generation of alpha.

Index composition offers opportunities and challenges
The MSCI World Healthcare Index is dominated by the 28 largest stocks in the index, which account for about three-quarters of the index capitalization, while the remaining 102 stocks – many of which are faster growing companies – account for only 25% of the index cap. This represents a broad and diverse field of opportunities for experienced active managers to identify valuation distortions and overweight or underweight specific stocks. 

open glightbox

 

Wide divergence of returns
+131% versus -58% – the wide spectrum of returns between the best and worst-performing stock in the MSCI World Healthcare Index in 2024 shows that investing selectively can deliver significant alpha. An ideal starting point for active management.

open glightbox

Why Bellevue?

Keeping a finger on the pulse of the healthcare market since 1993

Healthcare is a complex and highly dynamic market that require solid expertise in every aspect of the industry.

 

Established in 1993, Bellevue Asset Management is recognized as one of the pioneers in the healthcare space. We are proven experts in managing active, fundamental research-based healthcare investment vehicles. We boast a long and successful track record and have years of experience across the market cycle.

  • 1993

    Pioneer for healthcare investments 
    in Europe with the investment 
    company BB Biotech AG, 
    founded in 1993

  • 4.8 bn

    Assets under management in funds, institutional mandates and 
    investment companies in 
    the healthcare sector

  • 17 years

    Average relevant professional 
    experience of portfolio managers 
    and analysts in the healthcare 
    investment team

Invest in one of the world's largest growth markets – through Bellevue’s smart vehicle for excess return.

Bellevue Healthcare ETF

 Active portfolio management combined with the advantages of an ETF

With the actively managed Bellevue Healthcare ETF, Bellevue Asset Management’s vast expertise in the healthcare sector is integrated into an exchange-traded, transparent and cost-effective investment vehicle. Our healthcare experts invest in the most promising and relevant stocks from the global healthcare index MSCI World Healthcare – with the aim of outperforming this index.

Investment approach

Aiming for excellence – Bellevue picks the best of the best from more than 130 stocks with conviction 

  • The fund's investment universe is the MSCI World Healthcare Index, which comprises 130 to 140 large and mid-cap companies from more than 20 developed countries.
  • We pick 50 to 100 of the most promising stocks for our actively managed ETF portfolio based on the results of our fundamental research.
  • Our investment research assesses the relative strength of the fundamental data (e.g. competitive advantages), valuation metrics and risk/return considerations, research and differentiation scores (e.g. in talks with experts) as well as stock catalysts (e.g. regulatory approvals). 
  • The resulting conviction determines whether we overweight or underweight individual stocks relative to the index. 
  • The maximum range of weighting deviation is clearly defined for risk management purposes.
  • This active approach enables us to respond flexibly to shifting market dynamics within the global healthcare sector, with the aim of delivering enduring, tangible value to our investors.

Facts & Figures

 

DomicileIrland (UCITS ICAV)
Investment manager Bellevue Asset Management AG
Benchmark  MSCI World Healthcare Index
Investment approachActive, Fundamental Bottom-Up
EU SFDR 2019/2088Article 8
Listing dateSIX Swiss Exchange: September 18, 2025
Deutsche Börse Xetra: September 19, 2025
CurrenciesUSD (Base currency)
CHF (unhedged)
EUR (unhedged)
ListingsSIX Swiss Exchange (USD, CHF)
Deutsche Börse Xetra (EUR)
ISINIE000R6TN604
TickerUSD (CARE SW)
CHF (C4RE SW)
EUR (C4RE GY)

Have we sparked your interest?

We would be happy to send you further information. Please fill out the form below or contact your advisor.

For professional investors only.

 

*indicates required fields.
We respect your privacy and do not sell, rent or loan any identifiable information collected on this site. Any information that you give us will be treated with the utmost care and security. It will not be used in ways to which you have not consented.